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BM2 is the fourth integral membrane protein encoded by the influenza B virus genome. It is synthesized late in infection and transported
to the plasma membrane from where it is subsequently incorporated into progeny virus particles. It has recently been reported that BM2 has
ion channel activity and may be the functional homologue of the influenza A virus M2 protein acting as an ion channel involved in viral
entry. Using a reverse genetic approach it was not possible to recover virus which lacked BM2. A recombinant influenza B virus was
generated in which the BM2 AUG initiation codon was mutated to GUG. This decreased the efficiency of translation of BM2 protein such
that progeny virions contained only 1/8 the amount of BM2 seen in wild-type virus. The reduction in BM2 incorporation resulted in a
reduction in infectivity although there was no concomitant decrease in the numbers of virions released from the infected cells. These data
imply that the incorporation of sufficient BM2 protein into influenza B virions is required for infectivity of the virus particles.
D 2004 Elsevier Inc. All rights reserved.Keywords: BM2; Influenza B virus; VirusIntroduction
Influenza viruses are important human pathogens that
have been prevalent throughout the entire world for centu-
ries. Influenza viruses are within the family Orthomyxovir-
idae and are classified as either influenza virus type A, B, or
C. Influenza A virus was first isolated in 1933 (Smith et al.,
1933). In 1940, an influenza virus that had no antigenic
relationship to influenza A virus was isolated and termed
influenza B virus (Horsfall et al., 1940). Both influenza A
and B viruses are negative-stranded RNA viruses containing
eight gene segments that encode proteins of similar structure
and function. Segments 1–3 encode the polymerase pro-
teins, PB1, PB2, and PA. Segment 4 encodes the hemag-
glutinin protein HA; segment 5 encodes the nucleoprotein
NP; segment 6 encodes the neuraminidase enzyme NA;
segment 7 encodes the matrix protein M1; and segment0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.02.003
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E-mail address: w.s.barclay@reading.ac.uk (W. Barclay).8 encodes two proteins, the nonstructural protein NS1 and
nuclear export protein NEP.
Despite these similarities, influenza viruses contain
proteins unique to either type A or type B viruses. For
example, segment 2 of some influenza A viruses encodes
the PB1-F2 protein from a reading frame overlapping that
of the PB1 gene. PB1-F2 is thought to be involved in
virally induced apoptosis (Chen et al., 2001), but the ORF
is not seen in any influenza B viruses. Secondly, whereas
segment 6 of influenza A viruses encodes only one
protein, NA, segment 6 of influenza B viruses also
encodes the NB protein (Shaw et al., 1983) from an
open reading frame initiated four nucleotides before the
AUG for NA translation (Williams and Lamb, 1989). NB
is a 100 amino acid protein that is incorporated into
virions (Betakova et al., 1996; Brassard et al., 1996). It
has a single hydrophobic region that anchors the protein
in the membrane in a NoutCin orientation and lacks a
cleavable signal sequence, classifying it as a type III
integral membrane protein. The function of NB remains
unknown; however, it has recently been found that NB is
not essential for the production of viable virus in tissue
culture (Hatta and Kawaoka, 2003; DJ and WB unpub-
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channel activity (Chizhmakov et al., 1998; Fischer et
al., 2001; Sunstrom et al., 1996).
Further genetic differences are found between the
influenza type A and type B segment 7 RNAs. Thus,
although both virus types encode a second protein from
this RNA in addition to the M1 major structural gene, the
M2 and BM2 proteins are produced using quite different
coding strategies. The influenza A virus M2 protein is
translated from a spliced mRNA (Inglis and Brown, 1981;
Lamb and Choppin, 1981; Lamb et al., 1981), a process
controlled by the cellular SR splicing factor SF2/ASF
(Shih and Krug, 1996). M2 is a 96 amino acid integral
membrane protein expressed abundantly at the infected
cell surface and incorporated at lower levels into virions
(Jackson et al., 1991; Zebedee and Lamb, 1988). M2
forms a tetrameric channel (Holsinger and Lamb, 1991;
Sugrue and Hay, 1991) with ion channel activity (Pinto et
al., 1992; Wang et al., 1994) that can be blocked by the
anti-influenza drug amantadine (Hay, 1992; Pinto et al.,
1992; Wang et al., 1993). The M2 ion channel has two
functions (reviewed by Hay, 1992): firstly, it allows the
passage of protons from the endosome into the virion
core upon viral entry. This acidification leads to the
dissociation of vRNPs from the M1 protein allowing their
transport into the cytoplasm and ultimately to the nucleus
for replication. Secondly, M2 equilibrates the pH within
the trans-Golgi network (TGN) (Grambas and Hay, 1992;
Grambas et al., 1992). This facilitates the transport of HA
proteins containing multi-basic cleavage sites to the cell
surface in their native form as it prevents their low-pH
conformational change (Ohuchi et al., 1994; Takeuchi and
Lamb, 1994). The 19 amino acid transmembrane (TM)
domain forms the ion channel (Holsinger et al., 1994;
Pinto et al., 1992; Wang et al., 1993). Two key residues
in the TM domain are H37, which is thought to become
protonated under low pHout conditions leading to the
activation of the channel (Mould et al., 2000; Wang etFig. 1. Sequence changes introduced into the pPRM plasmid via site-directed mut
pPRBM2sst mutations were designed to knockout BM2 altogether. Nucleotides 76
forming the N-terminus of BM2 translated from the + 2 reading frame. Stop codon
larger type.al., 1995), and W41, which acts as the channel gate (Tang
et al., 2002).
The second protein encoded on influenza B virus RNA
segment 7 is BM2, a 109 amino acid type III integral
membrane protein that, like influenza A virus M2 protein,
is expressed at the cell surface and incorporated into virions
(Odagiri et al., 1999; Paterson et al., 2003; Watanabe et al.,
2003). BM2 is encoded from the second open reading frame
of a bicistronic mRNA with the capacity to encode a 195
amino acid protein (Briedis et al., 1982; DeBorde et al.,
1988; Hiebert et al., 1986). Translation is thought to occur
via a coupled termination and reinitiation process around the
BM1 stop codon via a UAAUG pentanucleotide motif
(Horvath et al., 1990). Interestingly, the BM2 TM domain
also contains a HXXXW motif reminiscent of that seen for
influenza A virus M2. It has recently been shown that BM2
expressed in Xenopus oocytes possesses ion channel activity
and that H19 and W23 are required. Furthermore, in mam-
malian cells, BM2 expression mediated a change in cyto-
plasmic pH when external pH was lowered and also affected
the pH of the TGN (Mould et al., 2003). That influenza B
virus requires an ion channel activity like that of influenza A
virus was implied by the observations that low pH can
dissociate M1 from RNP (Mould et al., 2003; Zhirnov,
1992). Thus, BM2 is likely to be the influenza B virus
functional homologue of the influenza A virus M2 protein
(Mould et al., 2003).
We have used a reverse genetics system recently es-
tablished in our laboratory for the rescue of recombinant
influenza B viruses (Jackson et al., 2002) to study the role
of the BM2 protein in the context of a viral infection. We
have attempted to generate recombinant viruses which
either lack the BM2 protein altogether to assess whether
it is essential for the production of viable virus, or that
have reduced levels of translated BM2 to assess at which
stage of viral infection BM2 is required. If BM2 is indeed
an ion channel, then we hypothesized that a reduction in
BM2 translation may reduce the efficiency of viral entry.agenesis. pPRBM2ss1 mutations were designed to reduce BM2 translation,
9–791 of the influenza B virus segment 7 are shown, as are the amino acids
s are underlined, nucleotide mutations are in bold, BM2 initiation codon in
Fig. 2. Synthesis of BM2 from pPRM, pPRBM2stop, and pPRBM2ss1
plasmids. 293-T cells were transfected with either plasmid together with the
four ‘helper’ plasmids required for synthesis of mRNA from vRNA. Thirty-
two hours after transfection cells were lysed in RIPA buffer and subjected to
SDS-PAGE and Western blotting using a rabbit anti-BM2 primary antibody
and a goat anti-rabbit HRP-conjugated secondary antibody.
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decreased infectivity compared to the isogenic wild-type
virions.Fig. 3. Synthesis of BM2 within Brec- and BM2ss1-infected MDCK cells and in
either virus and incubated at 34 jC. At 10 or 24 h postinfection cells were lysed in
(A) a mouse anti-NP monoclonal antibody followed by a goat anti-mouse HRP-c
followed by a goat anti-mouse HRP-conjugated secondary antibody, (C) and a
secondary antibody. Undiluted and 1/8 dilutions of concentrated Brec and BM2ss1
anti-BM2 primary antibody followed by a goat anti-rabbit HRP-conjugated second
goat anti-mouse HRP-conjugated secondary antibody.Results
Generation of a recombinant virus containing mutations
within the BM1–BM2 translation termination reinitiation
motif
Initiation of BM2 translation occurs via a termination
reinitiation motif (UAAUG) spanning nucleotides 769–
773 around the BM1 termination codon. We attempted to
knockout the BM2 protein using an established influenza
B virus reverse genetics system (Jackson et al., 2002).
We mutated this region of the B/Beijing/1/87 virus vRNA
segment 7 sequence within the pPRM rescue plasmid to
remove the BM2 initiation codon and to introduce two
tandem stop codons downstream in frame with the BM2
ORF (Fig. 1). The resultant plasmid, pPRBM2stop, was
co-transfected into 293-T cells with four ‘helper’ plasmids
which direct expression of the influenza B viral poly-
merases and nucleoprotein. As a control, the wild-type
pPRM plasmid was also transfected with the helper
plasmids. Western blot analysis of the resulting BM2-
expressing cells revealed three bands specific to BM2
migrating with molecular weights of 12, 17, and 24 kDa.
The predicted molecular weight for BM2 is 12 kDa. Thecorporation of BM2 into progeny virions. MDCK cells were infected with
RIPA buffer and lysates subjected to SDS-PAGE and Western blotting with
onjugated secondary antibody, (B) a mouse anti-M1 monoclonal antibody
rabbit anti-BM2 antibody followed by a goat anti-rabbit HRP-conjugated
virions were subjected to SDS-PAGE and Western blotting with (D) a rabbit
ary antibody, (E) and a mouse anti-NP monoclonal antibody followed by a
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Odagiri et al. (1999) to be a phosphorylated form of
BM2. We suggest that the 24-kDa species is a BM2
dimer. In contrast, no BM2 protein production was
detected as a result of the BM2stop mutations (Fig. 2).
Plasmid pPRBM2stop was then used in place of wild-
type pPRM plasmid in the influenza B virus rescue
system. However, on repeated occasions when wild type
virus Brec was recovered with high efficiency, virus
rescue was unsuccessful. Therefore, it is likely that the
BM2 protein is essential for the production of viable
virus.
We then replaced the BM2 initiation codon AUG with
GUG (Fig. 1). The aim was to reduce the amount of
BM2 protein translated. To ensure translation of BM1
did not run through the UAG stop codon, a second
termination signal was introduced directly after the first
by replacement of a C with an A at the +4 position of
the BM2 gene. This also resulted in a coding change to
the second codon of BM2 from Leu to Ile. The resultant
plasmid pPRBM2ss1 was co-transfected into 293-T cells
with the four plasmids expressing the viral polymerase
and nucleoprotein. Western blot analysis demonstrated
the production of BM2 within transfected cells although
at a lower concentration than BM2 protein expressed from
the pPRM wild-type plasmid (Fig. 2). The pPRBM2ss1Fig. 4. (A and B) Immunofluorescence analysis of Brec and BM2ss1-infected MDC
permeabilized in methanol/acetone 10 h postinfection. (A) Cells were stained
secondary antibody. (B) Cells were stained with a mouse anti-HA monoclonal antib
Flow cytometry analysis of Brec- and BM2ss1-infected Vero cells. Cells were
10 h postinfection. Cells were stained with (C) a mouse anti-HAmonoclonal antibod
a rabbit anti-NB antibody followed by a goat anti-rabbit FITC-conjugated seconda
cytometry. Mean fluorescence intensity (MFI) was determined using the WinMDIplasmid was then used in the rescue system in place of
wild-type pPRM plasmid. A recombinant virus designated
BM2ss1 was rescued. RNA segment 7 of the recombinant
virus BM2ss1 was fully sequenced to confirm the presence
of the desired mutations and the absence of nonspecific
changes in the RNA. Western blot analysis was performed
on infected Madin–Darby canine kidney (MDCK) cell
lysates to determine the efficiency of BM2ss1 BM2 protein
translation compared to that of wild-type virus. Fig. 3C
shows that BM2 protein concentration in cells at 10 h post-
infection is significantly reduced whereas similar concen-
trations of NP and M1 were present in each infected cell
lysate (Figs. 3A and B). Following lysate titration, we
estimate the reduction in BM2 to be approximately 8-fold
in BM2ss1-infected cells when compared to Brec-infected
cells (data not shown). By 24 h postinfection, the levels of
BM2 protein accumulated within BM2ss1-infected cells had
attained the same levels as those seen in Brec-infected cells
(Fig. 3C).
BM2 protein concentration was also determined in con-
centrated samples of wild-type and BM2ss1 virions har-
vested 48 h postinfection. There was an approximate 8-fold
decrease in BM2 protein concentration in BM2ss1 virions
when compared with wild-type virus particles (Fig. 3D)
whereas similar NP concentrations were observed (Fig. 3E).
Therefore, not only is BM2 present at a reduced level inK cells. Cells were infected with either virus at an MOI of 0.5 and fixed or
with a rabbit anti-BM2 antibody and a goat anti-rabbit FITC-conjugated
ody and a goat anti-mouse FITC-conjugated secondary antibody. (C and D)
infected with either virus at an MOI of 1 and harvested in PBS/EDTA
y followed by a goat anti-mouse FITC-conjugated secondary antibody or (D)
ry antibody. Cells were fixed in 4% paraformaldehyde and subjected to flow
2.8 software.
Fig. 5. Growth curve analysis of Brec- and BM2ss1-infected MDCK cells.
(A) Multistep growth curve. MDCK cells were infected with either Brec or
BM2ss1 virus at an MOI of 0.001 and supernatant samples harvested every
12 h. (B) Single step growth curve. Cells were infected at an MOI of 3 and
supernatant samples harvested every 3 h. Viral titers determined by plaque
assay and hemagglutination assay. All assays were performed in triplicate
and means with standard errors are shown.
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concentrations within virions when compared to wild-type
virus.
The effect of decreased BM2 translation on the transport
and distribution of HA within infected cells
MDCK cells were infected with 5  105 pfu/ml
(MOI of 0.5) Brec or BM2ss1 virus. Ten hours post-
infection, cells were fixed in methanol/acetone (1:1) and
used in immunofluorescence assays to study the distri-
bution of BM2 within infected cells. Brec-infected cells
showed the presence of BM2 within the cytoplasm and
a high level of staining within the Golgi apparatus (Fig.
4A). BM2ss1-infected cells also showed accumulation of
BM2 within the Golgi but cytoplasmic staining was
reduced in comparison to Brec-infected cells. Thus, this
assay also demonstrates the reduction in BM2 transla-
tion within BM2ss1-infected cells. Staining with an anti-
HA monoclonal antibody showed that both Brec- and
BM2ss1-infected cells demonstrated a similar distribution
of HA protein within the cytoplasm and at the cell
surface (Fig. 4B). In a more quantitative approach, the
cell surface expression of HA and also of NB was
measured by FACS analysis of Vero cells infected at an
MOI of 1 with either wild-type or mutant virus.
Interestingly, both proteins showed enhanced cell surface
expression in cells infected with the mutant virus (Figs.
4C and D). These results suggest that the transport of
the influenza B virus HA protein to the cell surface
does not rely on BM2 protein concentration and may
even be modified negatively by BM2. They also sug-
gest that the reduced incorporation of BM2 into
BM2ss1 virions is not due to a decrease in HA protein
at the cell surface.
BM2ss1 virus is attenuated in single step growth kinetics
To further characterize the BM2ss1 virus, its multistep
growth kinetics were analyzed. MDCK cells were infected
with BM2ss1 or Brec viruses in triplicate at an MOI of
0.001 and released viruses in supernatants harvested every
12 h for 3 days. The samples were titrated via plaque
assay to determine the infectious titer of each virus (pfu/
ml) and by hemagglutination assay to determine the
relative numbers of particles released (HAU/50 Al). Both
viruses obtained a peak viral titer at 48 h postinfection,
but the titer of BM2ss1 virus was slightly lower (Fig.
5A). However, there were similar numbers of viral
particles present in the samples detected by hemaggluti-
nation assay with a larger difference in particle/infectivity
ratio noted at the earlier time points. Next, a single step
growth curve assay was performed (Fig. 5B). MDCK
cells were infected with Brec or BM2ss1 in triplicate at
an MOI of 5 and samples harvested every 3 h postinfec-
tion. The BM2ss1 infectious titers were reduced 50-foldwhen compared with wild-type virus, whereas hemagglu-
tination assays showed that both viruses contained the
same number of viral particles at each time point. These
results suggest that a decrease in BM2 concentration
within BM2ss1 viral particles leads to a decrease in viral
infectivity.
A decreased concentration of BM2 protein within the virion
reduces the efficiency of infection
Influenza B virus nucleoprotein begins to accumulate
to high levels within the nucleus of infected cells 4–5
h postinfection and can be detected using an anti-NP
primary antibody. By measuring the number of NP posi-
tive cells at a specific early time point (e.g., 5 h post-
infection), one can determine how efficiently a virus
establishes infection in the monolayer. This method was
used to compare the efficiency of infection by BM2ss1
Fig. 6. Immunohistochemical analysis of Brec- and BM2ss1-infected MDCK cells. Cells were infected with virus standardized for HA titer in serial 10-fold
dilutions and fixed in methanol/acetone 5 h postinfection, then stained with a mouse anti-NP monoclonal antibody followed by a goat anti-mouse
h-galactosidase-conjugated secondary antibody and h-gal substrate.
D. Jackson et al. / Virology 322 (2004) 276–285 281and Brec virions. It was important for this experiment to
standardize virus input by HA titer rather than by infec-
tious titer to ensure that the relative infectivity of wild-
type and mutant virus particles would be measured. Thus,
BM2ss1 used in these experiments had an equal HA titer
to Brec, but its titer as determined by plaque assay was
10-fold lower. MDCK cells were infected with a range of
dilutions of each virus. At 5 h postinfection, the cells
were fixed in methanol/acetone (1:1) and stained for NP.
At each MOI, there is approximately a 4-fold reduction in
the number of cells staining positive following BM2ss1
exposure relative to the wild-type virus (Fig. 6). For
example, at an MOI of 0.01 (standardized relative to
wild-type virus), 56 Brec-infected cells were visualized
compared to 13 BM2ss1-infected cells. The same result
was achieved in immunofluorescence assays. The number
of infected cells for each virus dilution in both assays is
presented in Table 1. The data demonstrate that BM2ss1
virions initiated infection less efficiently than wild-type
virus.Table 1
Results of immunohistochemical and immunofluorescence assays present-
ing numbers of Brec- and BM2ss1-infected cells for each assay
Virus Viral antigen positive cells
MOI 0.01 MOI 0.001
Brec 56, 55 10, 9
BM2ss1 13, 15 3, 4Discussion
The influenza B virus BM2 protein is a type III integral
membrane protein that is expressed at the cell surface
(Paterson et al., 2003; Watanabe et al., 2003) and is
incorporated into virions (Odagiri et al., 1999). There are
many similarities between BM2 and the influenza A virus
M2 protein such as protein size, membrane topology, and a
HXXXW motif in the TM domain (Paterson et al., 2003).
The ion channel activity of the influenza A virus M2 protein
is involved in viral entry and equilibrating the pH of the
trans-Golgi network (TGN). Recent work has shown that
BM2 expressed in Xenopus oocytes possesses ion channel
activity (Mould et al., 2003). Our results are consistent with
a role for the BM2 protein as an ion channel required during
viral entry. However, we have not excluded the possibility
that the deficiency in BM2 results in a defect in the
packaging of viral RNA segments leading to a high propor-
tion of particles that lack the full genome complement.
Further experimentation to clarify this issue is ongoing.
We were unable to isolate a virus which lacked BM2
protein altogether. Because the reverse genetics system we
have developed routinely allows the recovery of 108 pfu/ml
recombinant virus at 7 days post-transfection (Jackson et al.,
2002), the inability to recover a BM2 knockout virus
implies that the production of BM2 protein is essential for
virus replication. It is possible that BM2 protein itself is not
required for infectivity, but that the ‘stop’ mutation has
affected a cis-acting RNA signal. In the present study, we
did not test whether the knockout mutation could be
complemented by an exogenous source of BM2 protein
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BM2. Several groups have addressed the requirement for
influenza A virus M2 protein using a reverse genetic
approach. However, it should be noted that due to the
coding strategy for M2, in none of these approaches has
production of an M2-related protein been absolutely pre-
vented. Complete deletion of M2 would demand changes to
the M1 open reading frame as the first nine codons of M1
and M2 overlap. However, recombinant viruses in which the
M2 transmembrane domain is either completely lacking,
replaced by heterologous sequence, or harbors deletions
known to abrogate ion channel activity have been described
(Takeda et al., 2002; Watanabe et al., 2001). Such viruses
were debilitated in growth at early time points and in vivo in
mice. The results suggest that M2 is important for efficient
viral replication in a single cycle but that an ion channel
may not be absolutely essential for virus viability in tissue
culture. It was suggested that in the absence of M2, there
may be another way for protons to enter the virion, perhaps
through pores generated by fusion of HA with the virus
membrane. Why this mechanism would not also compen-
sate for influenza B viruses lacking a BM2 ion channel is
not clear.
Although complete removal of BM2 did not cause viable
virus, a recombinant virus in which BM2 protein was
substantially reduced was rescued. This was achieved by
mutation of the BM2 AUG initiation codon to GUG, which
is used for translation initiation infrequently in Escherichia
coli (Kozak, 1983) and occasionally in eukaryotes (Abramc-
zyk et al., 2003; Boeck et al., 1992; Fuxe et al., 2000).
Efficiency of initiation from GUG is usually lower than
from an AUG in the same context (Kozak, 1989). We
estimate that in the context of the virus infection 4- to 8-
fold less BM2 was translated from the BM2ss1 segment 7
mRNA. Although this suggests a rather high frequency for
translation initiation from the non-canonical codon, it
should be borne in mind that the GUG codon is being used
in the unusual context of coupled termination–reinitiation
and as such may not be subject to the regular rules for the
initiation process. The accumulation of M1 protein in
infected cells was not affected by the engineered mutation
so any phenotype of the mutant virus could be directly
attributed to a deficit in BM2 expression.
Purified virions of the mutant virus also incorporated
approximately 8-fold less BM2 than wild-type virus. These
data might be helpful in understanding how BM2 is
recruited into the virion during assembly. For influenza A
virus M2, Park et al. (1998) have suggested that incorpora-
tion is specific and occurs via an interaction of the M2
ectodomain with another viral component, possibly HA. If
this were also the case for influenza B viruses, then the low
level of BM2 protein in BM2ss1 mutant virions might be
accounted for by a decrease in the level of HA available for
assembly at the cell surface. However, analysis of protein
expression in cells infected with BM2ss1 virus showed that
although intracellular accumulation of BM2 was reduced at10 h postinfection when compared to wild-type virus, levels
of cell surface HAwere actually increased, as were levels of
NB. One possible explanation for this observation would be
that wild-type levels of BM2, like influenza A virus M2,
interfere with trafficking of membrane proteins due to the
distension of the Golgi apparatus which results from dereg-
ulation of the internal organelle pH (Sakaguchi et al., 1996).
In cells infected with mutant virus, the decrease in BM2
expression may be sufficient to significantly reduce or even
abrogate this effect. The decrease in BM2 levels in virions
could imply that BM2 is passively included in virions rather
than actively recruited by another viral protein. Thus,
lowered levels in the cell are directly reflected by lower
incorporation into virions. Clarification of the mechanism
for BM2 incorporation awaits further experimentation.
The ss1 mutation had a significant effect on viral
replication which was particularly apparent during the early
release phase of progeny virions. Although it is possible that
the Leu to Ile change at residue 2 of the BM2 protein
affected BM2 activity, it is more likely that the mutant
phenotype was due to the reduction in BM2 incorporated
into virions. At 10 h postinfection when there was an 8-fold
reduction in BM2 expression in infected cells, there was up
to a 50-fold reduction in the infectivity of released particles.
Later, between 24 and 36 h postinfection, when levels of
BM2 were comparable in mutant and wild-type virus-
infected cells, BM2ss1 infectivity increased to reach levels
only half a log less than for wild-type virus. Thus most of
the virus particles produced in the first few hours of budding
where BM2 is limited may not incorporate enough BM2 for
progeny virus particles to be infectious. Influenza A virus
particles contain between 14 and 68 incorporated M2
molecules (Zebedee and Lamb, 1988). We estimate there
to be between 20 and 50 molecules of BM2 in each
influenza B virus particle (WB. unpublished data). Thus
the BM2 incorporation level in wild-type virus is probably
already close to minimal. Interestingly, the number of virus
particles released was not affected by the decrease in BM2
concentration at the infected cell surface. Hemagglutination
assay (HA) results demonstrated a similar number of viral
particles were released from cells infected with either virus
at all time points. This suggests that a decrease in BM2
levels has little effect on viral assembly and release. In
contrast, a reduced cell surface expression of M2 resulting
from treatment with a monoclonal antibody caused a reduc-
tion in the number of progeny virions released (Hughey et
al., 1995).
If BM2 is an ion channel involved in viral entry, a
decrease in BM2 incorporation within the virion should
lead to a decrease in the efficiency of viral entry. Indeed, in
the present study, an immunohistochemical assay which
measured early events in infection detected a 4-fold reduc-
tion in the number of cells infected with BM2ss1 compared
to wild-type virus. A similar result was achieved by mea-
suring the incorporation of radiolabelled amino acids into
viral proteins from 2 to 10 h postinfection (data not shown).
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viral proteins such as NP, HA, and NS1 than BM2ss1-
infected cells at each time point, indicating that wild-type
viral entry is more efficient.
If BM2 is an ion channel, then a decrease in its
incorporation may not permit sufficient numbers of protons
to cross the membrane to allow dissociation of M1 from
vRNPs. This would explain the decrease in infectivity of
BM2ss1 virus in comparison to wild-type virus. Indeed, it
appears that, unlike influenza A viruses (Watanabe et al.,
2001), influenza B viruses absolutely require ion channel
activity to be viable. Interestingly, complex formation by
vRNP, M1, and NEP differs between influenza A and B
viruses (Imai et al., 2003). Alternatively, BM2 may have
another function within the virus replication cycle whose
loss prevents the recovery of BM2 knockout virus. This
study supports the hypothesis that BM2 is an ion channel
required for virus disassembly (Paterson et al., 2003).
Further work could include mutational analysis of the
BM2 TM domain which should be key to the activity of
the viral ion channel. It is noteworthy that this is the only
region of the BM2 protein that is totally conserved among
virtually all available BM2 sequences. However, definitive
proof that BM2 is an ion channel whose activity is required
for virus replication requires a drug that blocks the channel,
which is as yet to be discovered.Materials and methods
Cell culture and transfections
293-T cells and Madin–Darby canine kidney (MDCK)
cells were maintained in Dulbecco’s modified Eagle’s
medium (Life Technologies) supplemented with 10% fetal
calf serum, 1% glutamine (200 mM), 2% nonessential
amino acids, and 1% penicillin–streptomycin (5000 IU/
ml; 5000 Al) at 37 jC and 5% CO2. Transfections were
performed on 6-well (immunofluorescence assay) or 12-
well (Western blot assay and virus rescue) plates of 80%
confluent 293-T cells in 3% DMEM. For five-plasmid
transfections, 0.5 Ag of each of pCIPB1, pCIPB2, pCIPA,
and pPRM and 1 Ag of pCINP were mixed with 140
Al serum-free DMEM and 10 Al FuGENE 6 transfection
reagent (Roche) for 15 min at room temperature, added to
cells, and incubated at 34 jC for 32 h.
Virus rescue and infections
Influenza B virus rescue was performed as described
previously (Jackson et al., 2002). Briefly, 0.5 Ag of
pPRPB1, pPRPB2, pPRPA, pPRHA, pPRNP, pPRNA,
pPRM, pPRNS, pCIPB1, pCIPB2, and pCIPA and 1 Ag of
pCINP were transfected into 80% confluent 293-T cells on a
12-well plate and incubated at 34 jC. Sixteen hours after
transfection, the 293-T cells were co-cultured with MDCKcells in the presence of 2.5 Ag of trypsin/ml. Cytopathic
effect was observed 68–72 h post-transfection. For the
production of pPRBM2stop and pPRBM2ss1 plasmids,
site-directed mutagenesis (Stratagene) was performed using
the pPRM plasmid as template.
For virus infections of MDCK cells, the virus was
allowed to adsorb to cells at 34 jC for 1 h then removed
and serum-free DMEM containing 2.5 Ag of trypsin/ml was
added followed by incubation at 34 jC. To concentrate
virus, 40 ml of 1  107 pfu/ml virus was centrifuged at
25000 rpm through 30% sucrose for 2.5 h. Virus pellets
were resuspended in 50 Al NTE buffer (150 mM NaCl; 10
mM Tris–HCl pH7.5; 1 mM EDTA). Multistep growth
curve infections were performed in 6-well plates of conflu-
ent MDCK cells using an MOI of 0.001 and supernatant
samples were harvested every 12 h until 72 h postinfection.
Single-step growth curve infections were performed in a
similar way using an MOI of 5 and sampling every 3 h until
24 h postinfection. Samples were then used in plaque assay
experiments.
Plaque assays and hemagglutination assays
Harvested supernatant samples were titrated in serial 10-
fold dilutions in 200 Al volumes of serum-free DMEM on
12-well plates of confluent MDCK cells. After adsorption at
34 jC for 1 h, the virus was removed and cells were
covered with overlay media (EMEM containing 7.5% BSA,
200 mM L-glutamine, 7.5% NaHCO3, 1 M HEPES, 1%
dextran, 10000 units/ml penicillin, 10 mg/ml streptomycin,
0.6% oxoid agar) and incubated at 34 jC. Four days later,
plaque number was counted and virus titers in pfu/ml were
determined for each sample. For hemagglutination assays,
virus samples were titrated in V-bottomed 96-well plates
in serial 2-fold dilutions in 50 Al volumes of PBS. Fifty
microliters of 0.5% chicken red blood cells was added and
plates incubated on ice for 1 h. Virus titers in HA units/50
Al were determined for each sample.
SDS-PAGE and Western blotting
Confluent MDCK cells on 12-well plates were infected at
an MOI of 1 and incubated at 34 jC for 16 h. Cells were
lysed in 200 Al RIPA buffer (100 mM NaCl, 50 mM
iodoacetamide, 1% Nonidet-P40, 0.1% SDS, 0.5% sodium
deoxycholate, 20 mM Tris–HCl, pH 7.5) and proteins
separated by SDS-PAGE on a 15% polyacrylamide gel.
Proteins were transferred to a PVDF membrane and blocked
overnight in 5% dried milk (Marvel) blocking buffer.
Western blotting was performed using a mouse anti-NP
monoclonal antibody (www.Immunologicalsdirect.com) at
a 1/500 dilution in PBS–Marvel–0.1% Tween, a mouse
anti-M1 monoclonal antibody (www.immunologicalsdirect.
com) at a 1/2000 dilution, or a rabbit anti-BM2 antibody at a
1/4000 dilution as the primary antibody. Membranes were
washed in PBS–0.1% Tween followed by the addition of a
D. Jackson et al. / Virology 322 (2004) 276–285284goat anti-mouse (1/10000 dilution) or goat anti-rabbit (1/
4000 dilution) HRP-conjugated secondary antibody
(www.Immunologicalsdirect.com). ECL Western blotting
detection reagent (Amersham Biosciences) was added to
each membrane according to the manufacturers instructions
and membranes were developed on Hyperfilm ECL chemi-
luminescent film (Amersham Biosciences).
Immunohistochemical and immunofluorescence assays
For the immunohistochemical assay, MDCK cells were
grown in 6-well plates, and for the immunofluorescence
assay, MDCK cells were grown on 22-mm diameter glass
coverslips in 6-well plates. Confluent MDCK cells were
infected at a range of MOIs and incubated at 34 jC for 5 h.
Cells were fixed in methanol/acetone (1:1) for 15 min and
blocked in PBS–0.5% BSA–0.02% Na azide for 1 h at
room temperature. The mouse anti-NP monoclonal antibody
at a dilution of 1/100 was added to the cells for 1 h at room
temperature. For the immunohistochemical assay, a goat
anti-mouse h-galactosidase-conjugated secondary antibody
was added at a 1/100 dilution for 1 h at room temperature
followed by the addition of h-gal substrate (0.5% X-gal,
10% CN buffer [30 mM Kferricyanide, 30 mM Kferrocya-
nide, 10 mM MgCl2], in PBS) and incubated at 37 jC for 30
min. For the immunofluorescence assay, a goat anti-mouse
FITC-conjugated secondary antibody was added to the cells
at a dilution of 1/100 for 1 h at room temperature. Cover-
slips were then mounted on slides and viewed on a Leica
confocal microscope. All antibodies used were obtained
from www.Immunologicalsdirect.com.
To study the distribution of BM2 and HA within
infected cells, confluent MDCK cells grown on glass
coverslips in 6-well plates were infected with 5  105
pfu/ml Brec or BM2ss1 virus. Ten hours postinfection,
cells were fixed in methanol/acetone (1:1) for 15 min,
washed in PBS, and blocked in PBS–0.5% BSA–0.02%
Na azide for 1 h at room temperature. A mouse anti-HA
monoclonal antibody (Harlan Serolabs) at a 1/100 dilution
or a rabbit anti-BM2 antibody at a 1/200 dilution was
added to the cells for 1 h at room temperature. Cells were
washed three times in PBS and either an anti-mouse or
anti-rabbit FITC-conjugated secondary antibody at a 1/100
dilution was added to the cells for 1 h at room tempera-
ture. Coverslips were then mounted on slides and viewed
on a Leica confocal microscope.
Flow cytometry of virus-infected cells
Vero cells were grown in 6-well plates. Two wells were
infected with 106 pfu/ml Brec or BM2ss1 virus and incu-
bated at 34 jC for 16 h. Cells were harvested in 1 ml PBS–
EDTA and pooled. Two milliliters of serum-free DMEM per
well of cells was added and samples were centrifuged at
2000 rpm for 3 min. Cells were resuspended in 500 Al of
either a mouse anti-HA monoclonal antibody at a 1/100dilution or a rabbit anti-NB antibody at a 1/200 dilution in
PBS–0.5% BSA–0.02% Na azide (PBN). Cells were incu-
bated at room temperature for 1 h on a tube rotator. Cells
were washed three times in PBN followed by centrifugation
at 2000 rpm for 3 min. Cells were resuspended in 500 Al of
either an anti-mouse or anti-rabbit FITC-conjugated second-
ary antibody at a 1/100 dilution in PBN and incubated at
room temperature for 1 h on a tube rotator. Cells were
washed three times followed by centrifugation at 2000 rpm
for 3 min. Cells were fixed in 500 Al CellFix (Becton
Dickinson) and added to 1 ml of FACSflow (Becton Dick-
inson). Samples were subjected to flow cytometry in a
Becton Dickinson FACScan and results analyzed on
WinMDI 2.8 software.Acknowledgments
We are grateful to Daniel Fox for producing recombinant
BM2 used as antigen for raising an anti-BM2 antiserum. DJ
is funded by a BBSRC CASE award.References
Abramczyk, D., Tchorzewski, M., Grankowski, N., 2003. Non-AUG trans-
lation initiation of mRNA encoding acidic ribosomal P2A protein in
Candida albicans. Yeast 20, 1045–1052.
Betakova, T., Nermut, M.V., Hay, A.J., 1996. The NB protein is an integral
component of the membrane of influenza B virus. J. Gen. Virol. 77,
2689–2694.
Boeck, R., Curran, J., Matsuoka, Y., Compans, R., Kolakofsky, D., 1992.
The parainfluenza virus type 1 P/C gene uses a very efficient GUG
codon to start its CVprotein. J. Virol. 66, 1765–1768.
Brassard, D.L., Leser, G.P., Lamb, R.A., 1996. Influenza B virus NB
glycoprotein is a component of the virion. Virology 220, 350–360.
Briedis, D.J., Lamb, R.A., Choppin, P.W., 1982. Sequence of RNA seg-
ment 7 of the influenza B virus genome: partial amino acid homology
between the membrane proteins (M1) of influenza A and B viruses and
conservation of a second open reading frame. Virology 116, 581–588.
Chen, W., Calvo, P.A., Malide, D., Gibbs, J., Schubert, U., Bacik, I., Basta,
S., O’Neill, R., Schickli, J., Palese, P., Henklein, P., Bennink, J.R.,
Yewdell, J.W., 2001. A novel influenza A virus mitochondrial protein
that induces cell death. Nat. Med. 7, 1306–1312.
Chizhmakov, I., Ogden, D., Betakova, T., Phillips, A., Hay, A.J., 1998. Cl
and H+ permeability formed by expression of NB protein from influ-
enza B virus. Biophys. J. 74, A319.
DeBorde, D.C., Donabedian, A.M., Herlocher, M.L., Naeve, C.W., Maas-
sab, H.F., 1988. Sequence comparison of wild-type and cold-adapted B/
Ann/Arbor/1/66 influenza virus genes. Virology 163, 429–443.
Fischer, W.B., Pitkeathly, M., Sansom, M.S.P., 2001. Amantadine blocks
channel activity of the transmembrane segment of the NB protein from
influenza B. Eur. Biophys. J. 30, 416–420.
Fuxe, J., Raschperger, E., Pettersson, R.F., 2000. Translation of p15.5
(INK4B), an N-terminally extended and fully active form of p15
(INK4B), is initiated from an upstream GUG codon. Oncogene 19,
1724–1728.
Grambas, S., Hay, A.J., 1992. Maturation of influenza A virus hemagglu-
tinin—Estimates of the pH encountered during transport and its regu-
lation by the M2 protein. Virology 190, 11–18.
Grambas, S., Bennett, M.S., Hay, A.J., 1992. Influence of amantadine
resistance mutations on the pH regulatory function of the M2 protein
of influenza A viruses. Virology 191, 541–549.
D. Jackson et al. / Virology 322 (2004) 276–285 285Hatta, M., Kawaoka, Y., 2003. The NB protein of influenza B virus is not
necessary for virus replication in vitro. J. Virol. 77, 6050–6054.
Hay, A.J., 1992. The action of adamantanamines against influenza A
viruses: inhibition of the M2 ion channel protein. Semin. Virol. 3,
21–30.
Hiebert, S.W., Williams, M.A., Lamb, R.A., 1986. Nucleotide sequence of
RNA segment 7 of influenza B/Singapore/222/79: maintenance of a
second large open reading frame. Virology 155, 747–751.
Holsinger, L.J., Lamb, R.A., 1991. Influenza virus M2 integral membrane
protein is a homotetramer stabilized by formation of disulphide bonds.
Virology 183, 32–43.
Holsinger, L.J., Nichani, D., Pinto, L.H., Lamb, R.A., 1994. Influenza A
virus M2 ion channel protein: a structure– function analysis. J. Virol.
68, 1551–1563.
Horsfall, F.L.J., Lennette, E.H., Rickard, E.R., Andrewes, C.H., Smith, W.,
Stuart-Harris, C.H., 1940. The nomenclature of influenza. Lancet ii, 413.
Horvath, C.M., Williams, M.A., Lamb, R.A., 1990. Eukaryotic coupled
translation of tandem cistrons: identification of the influenza B virus
BM2 polypeptide. EMBO J. 9, 2639–2647.
Hughey, P.G., Roberts, P.C., Holsinger, L.J., Zebedee, S.L., Lamb, R.A.,
Compans, R.W., 1995. Effects of antibody to the influenza A virus M2
protein on M2 surface expression and virus assembly. Virology 212,
411–421.
Imai, M., Watanabe, S., Odagiri, T., 2003. Influenza B virus NS2, a nuclear
export protein, directly associates with the viral ribonucleoprotein com-
plex. Arch. Virol. 148, 1873–1884.
Inglis, S.C., Brown, C.M., 1981. Spliced and unspliced RNAs encoded
by virion RNA segment 7 of influenza virus. Nucleic Acids Res. 9,
2727–2740.
Jackson, D.C., Tang, X.-L., Murti, K.G., Webster, R.G., Tregear, G.W.,
Bean, W.J., 1991. Electron microscopic evidence for the association
of M2 protein with the influenza virion. Arch. Virol. 118, 199–207.
Jackson, D., Cadman, A., Zurcher, T., Barclay, W.S., 2002. A reverse
genetics approach for recovery of recombinant influenza B viruses
entirely from cDNA. J. Virol. 76, 11744–11747.
Kozak, M., 1983. Comparison of initiation of protein synthesis in prokar-
yotes, eukaryotes and organelles. Microbiol. Rev. 47, 1–45.
Kozak, M., 1989. Context events and inefficient initiation at non-AUG
codons in eucaryotic cell-free translation systems. Mol. Cell. Biol. 9,
5073–5080.
Lamb, R.A., Choppin, P.W., 1981. Identification of a second protein (M2)
encoded by RNA segment 7 of influenza virus. Virology 112, 729–737.
Lamb, R.A., Lai, C.-J., Choppin, P.W., 1981. Sequences of mRNAs derived
from genome RNA segment 7 of influenza virus: colinear and inter-
rupted mRNAs code for overlapping proteins. Proc. Natl. Acad. Sci.
U.S.A. 78, 4170–4174.
Mould, J.A., Li, H.-C., Dudlak, C.S., Lear, J.D., Pekosz, A., Lamb, R.A.,
Pinto, L.H., 2000. Mechanism for proton conductance of the M2 ion
channel of influenza A virus. J. Biol. Chem. 275, 8592–8599.
Mould, J.A., Paterson, R.G., Takeda, M., Ohigashi, Y., Venkataraman, P.,
Lamb, R.A., Pinto, L.H., 2003. Influenza B virus BM2 protein has ion
channel activity that conducts protons across membranes. Dev. Cell 5,
175–184.
Odagiri, T., Hong, J., Ohara, Y., 1999. The BM2 protein of influenza B
virus is synthesized in the late phase of infection and incorporated into
virions as a subviral component. J. Gen. Virol. 80, 2573–2581.
Ohuchi, M., Cramer, A., Vey, M., Ohuchi, R., Garten, W., Klenk, H.-D.,
1994. Rescue of vector-expressed fowl plague virus hemagglutinin in
biologically active form by acidotropic agents and coexpressed M2
protein. J. Virol. 68, 920–926.Park, E.K., Castrucci, M.R., Portner, A., Kawaoka, Y., 1998. The M2
ectodomain is important for its incorporation into influenza A virions.
J. Virol. 72, 2449–2455.
Paterson, R.G., Takeda, M., Ohigashi, Y., Pinto, L.H., Lamb, R.A., 2003.
Influenza B virus BM2 protein is an oligomeric integral membrane
protein expressed at the cell surface. Virology 306, 7–17.
Pinto, L.H., Holsinger, L.J., Lamb, R.A., 1992. Influenza virus M2 protein
has ion channel activity. Cell 69, 517–528.
Sakaguchi, T., Leser, G.P., Lamb, R.A., 1996. The ion channel activity of
the influenza virus M2 protein affects transport through the Golgi ap-
paratus. J. Cell Biol. 133, 733–747.
Shaw, M.W., Choppin, P.W., Lamb, R.A., 1983. A previously unrecog-
nised influenza B virus glycoprotein from a bicistronic mRNA that
also encodes the viral neuraminidase. Proc. Natl. Acad. Sci. U.S.A.
80, 4879–4883.
Shih, S.-R., Krug, R.M., 1996. Novel exploitation of a nuclear function by
influenza virus: the cellular SF2/ASF splicing factor controls the
amount of the essential viral M2 ion channel protein in infected cells.
EMBO J. 15, 5415–5427.
Smith, W., Andrewes, C.H., Laidlaw, P.P., 1933. A virus obtained from
influenza patients. Lancet ii, 66–68.
Sugrue, R.J., Hay, A.J., 1991. Structural characteristics of the M2 protein
of influenza A viruses: evidence that it forms a tetrameric channel.
Virology 180, 617–624.
Sunstrom, N.A., Premkumar, L.S., Premkumar, A., Ewart, G., Cox, G.B.,
Gage, P.W., 1996. Ion channels formed by NB, an influenza B virus
protein. J. Membr. Biol. 150, 127–132.
Takeda, M., Pekosz, A., Shuck, K., Pinto, L.H., Lamb, R.A., 2002. Influ-
enza A virus M2 ion channel activity is essential for efficient replication
in tissue culture. J. Virol. 76, 1391–1399.
Takeuchi, K., Lamb, R.A., 1994. Influenza virus M2 protein ion channel
activity stabilizes the native form of fowl plague virus hemagglutinin
during intracellular transport. J. Virol. 68, 911–919.
Tang, Y., Zaitseva, F., Lamb, R.A., Pinto, L.H., 2002. The gate of the
influenza virus M2 proton channel is formed by a single tryptophan
residue. J. Biol. Chem. 277, 39880–39886.
Wang, C., Takeuchi, K., Pinto, L.H., Lamb, R.A., 1993. Ion channel ac-
tivity of influenza A virus M2 protein: characterization of the amanta-
dine block. J. Virol. 67, 5585–5594.
Wang, C., Lamb, R.A., Pinto, L.H., 1994. Direct measurement of the
influenza A virus M2 protein ion channel activity in mammalian cells.
Virology 205, 133–140.
Wang, C., Lamb, R.A., Pinto, L.H., 1995. Activation of the M2 ion channel
of influenza virus: a role for the transmembrane domain histidine re-
sidue. Biophys. J. 69, 1363–1371.
Watanabe, T., Watanabe, S., Ito, H., Kida, H., Kawaoka, Y., 2001. Influenza
A virus can undergo multiple cycles of replication without M2 ion
channel activity. J. Virol. 75, 5656–5662.
Watanabe, S., Imai, M., Ohara, Y., Odagiri, T., 2003. Influenza B virus
BM2 protein is transported through the trans-Golgi network as an
integral membrane protein. J. Virol. 77, 10630–10637.
Williams, M.A., Lamb, R.A., 1989. Effect of mutations and deletions in a
bicistronic mRNA on the synthesis of influenza B virus NB and NA
glycoproteins. J. Virol. 63, 28–35.
Zebedee, S.L., Lamb, R.A., 1988. Influenza A virus M2 protein: monoclo-
nal antibody restriction of virus growth and detection of M2 in virions.
J. Virol. 62, 2762–2772.
Zhirnov, O.P., 1992. Isolation of matrix protein M1 from influenza viruses
by acid-dependent extraction with non-ionic detergent. Virology 186,
324–330.
